Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for memory and attention in mild cognitive impairment
2014-003117-28Phase 4Active
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate in Mild Cognitive Impairment (MCI). Primary endpoints: Immediate recall total words in verbal learning test, Delayed recall total words in verbal learning test and 4 more. Started Aug 2014; status: active.
02
Drugs
methylphenidate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on 2014-003117-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003117-28.